Bacterfield was founded in September 2006 by a major pharmaceutical industry investment group: MM Grupp. An industrial group of international standing , focused on innovative investment in advanced technologies, but above all a key player in pharmaceutical and veterinary distribution in the Baltic States and Scandinavia.

Bacterfield has been able to benefit from the very best international resources: experienced scientists, nutritionists and veterinary surgeons who have developed a new probiotic formula that has attained the highest standards in terms of quality and efficiency. A new generation of pet food that is revolutionising the sector by creating the first alimentary program based on live probiotics with a concentration of 10⁹ CFU per kilogram of complete feed.

Read more about the company in Bacterfield.com.